References
- Qureshi R, Puvanesarajah V, Jain A, et al. Perioperative management of blood loss in spine surgery. Clin Spine Surg. 2017;30:383–388.
- Mummaneni PV, Dhall SS, Eck JC, et al. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. part 11: interbody techniques for lumbar fusion. SPI. 2014;21:67–74.
- Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135–148.
- Park Y, Ha JW. Comparison of one-level posterior lumbar interbody fusion performed with a minimally invasive approach or a traditional open approach. Spine. 2007;32:537–543.
- Price JS, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ. 2015;18:777–786.
- Xu D, Ren Z, Chen X, et al. A randomized controlled trial on effects of different hemostatic sponges in posterior spinal fusion surgeries. BMC Surg. 2016;16:80–85.
- Menovsky T, Plazier M, Rasschaert R, et al. Massive swelling of Surgicel® Fibrillar™ hemostat after spinal surgery. Case report and a review of the literature. Minim Invasive Neurosurg. 2011;54:257–259.
- Fuchs M, Iooss P, Srour R, et al. Surgiflo® without thrombin, a credible alternative to Floseal® in spinal surgery. Pharmacien Hospitalier Et Clinicien. 2015;50:289–295.
- Gazzeri R, De BC, Galarza M. Use of a thrombin-gelatin hemostatic matrix (Surgiflo®) in spinal surgery. Surg Tech Int. 2014;25:280–285.
- Xu D, Zhuang Q, Li Z, et al. A randomized controlled trial on the effects of collagen sponge and topical tranexamic acid in posterior spinal fusion surgeries. J Orthop Surg Res. 2017;12:166–172.
- Wu J, Jin Y, Zhang J, et al. Hemostatic techniques following multilevel posterior lumbar spine surgery. Clin Spine Surg. 2014;27:442–446.
- Lu D, Ding WG, Sheng HF, et al. The efficacy and safety of using a bipolar sealer to prevent blood loss in spine surgery: a meta-analysis. Int J Surg. 2017;46:37–46.
- Sabel M, Stummer W. Haemostasis in spine surgery. the use of local agents: Surgicel® and Surgifoam®. Eur Spine J. 2004;13:S97–S101.
- Alander DH, Stauffer ES. Gelfoam-induced acute quadriparesis after cervical decompression and fusion. Spine. 1995;20:970–971.
- Rodbelt AR, Miles JB, Foy PM, et al. Intraspinal oxidised cellulose (Surgicel®) causing delayed paraplegia after thoracotomy – a report of three cases. Ann R Coll Surg Engl. 2002;84:97–99.
- Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13:S3–S5.
- Renkens KL, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine. 2001;26:1645–1650.
- Helenius I, Keskinen H, Syvanen J, et al. Gelatine matrix with human thrombin decreases blood loss in adolescents undergoing posterior spinal fusion for idiopathic scoliosis. Spine. 2016;98B:395–401.
- Kumar S, Goyal K, Dubey S, et al. Anaphylactic reaction after autologous blood transfusion: a case report and review of the literature. Asian J Neurosurg. 2015;10:145–147.
- Zou H, Li Z, Sheng H, et al. Intraoperative blood loss, postoperative drainage, and recovery in patients undergoing lumbar spinal surgery. BMC Surg. 2015;15:76.
- Schroeder GD, Kurd MF, Kepler CK, et al. Postoperative epidural hematomas in the lumbar spine. J Spinal Disord Tech. 2015;28:313–318.
- Hasan M, Mehmet E, Sebnem O. Are drains useful for lumbar disc surgery? A prospective, randomized clinical study. Clin Spine Surg. 2006;19:171–177.
- Cho SK, Yi JS, Park MS, et al. Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. J Bone Joint Surg Am. 2012;94:1952–1958.
- ter Gunne AFP, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine. 2009;34:1422–1428.